• Demo Image

Childhood Myopia Progression Study

This study is CLOSED to Enrollment

I’m Interested!

Why we are doing this study:
To see if an investigational eye drop used daily before bedtime can safely slow the progression of myopia in children.

Who can be in the study:
Your child may be eligible to participate if:

  • They are 3 to 10 years of age.
  • Their current glasses prescription is between -0.50 and -6.00 with no more than -1.50 diopters of astigmatism.

Further screening questions will be asked prior to scheduling an appointment.

What the study involves:
This 4 year study will be conducted in two stages: a 3 year treatment period followed by an additional 1 year period. During the study you or your child will be asked to:

  • Use study medication as instructed by the study doctor.
  • Attend study visits every 3 months at the Clinical Vision Research Center at SUNY Optometry at which time we will dispense study medication and perform study medication accountability.
  • Attend visits every 6 months to have eye health checked and answer questions about medication use.
  • Unless medically needed, your child will not be able to take certain medications by mouth or use any other eye drops, except for the study drops, during the study. Occasional (not every day) use of non-preserved artificial tears is allowed.

Will you directly benefit from the study?
Your child’s myopia may or may not progress while he/she is in this study. The results of this study may help children with myopia in the future.

Other things you should know about the study:
Compensation can be up to $1,080.00 for office visits and up to $800 allowance for glasses or spherical soft contact lenses. Female subjects of childbearing potential will be asked to undergo a urine pregnancy test at each visit and those who are sexually active must agree to use adequate birth control during the study. Male subjects who are sexually active, must agree to protect their partner from becoming pregnant during the study.

Principal Investigator: Dr. Erica Schulman
For more information, contact the Clinical Vision Research Center.